ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
258.31
+0.70 (0.27%)
At close: Jan 30, 2026, 4:00 PM EST
258.30
-0.01 (0.00%)
After-hours: Jan 30, 2026, 7:06 PM EST
ResMed Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$292.20
Upside
+13.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $311 → $314 | Buy | Maintains | $311 → $314 | +21.56% | Jan 30, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $270 → $275 | Hold | Maintains | $270 → $275 | +6.46% | Jan 30, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $265 → $270 | Hold | Maintains | $265 → $270 | +4.53% | Jan 30, 2026 |
| Stifel | Stifel | Hold Maintains $260 → $265 | Hold | Maintains | $260 → $265 | +2.59% | Jan 30, 2026 |
| Stifel | Stifel | Hold Maintains $270 → $260 | Hold | Maintains | $270 → $260 | +0.65% | Dec 18, 2025 |
| Baird | Baird | Buy → Hold Downgrades $300 → $275 | Buy → Hold | Downgrades | $300 → $275 | +6.46% | Dec 16, 2025 |
| Baird | Baird | Buy Maintains $320 → $300 | Buy | Maintains | $320 → $300 | +16.14% | Nov 3, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $300 → $303 | Buy | Maintains | $300 → $303 | +17.30% | Oct 31, 2025 |
| Keybanc | Keybanc | Buy Maintains $298 → $299 | Buy | Maintains | $298 → $299 | +15.75% | Oct 31, 2025 |
| Mizuho | Mizuho | Buy Maintains $310 → $300 | Buy | Maintains | $310 → $300 | +16.14% | Oct 31, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $298 → $304 | Buy | Maintains | $298 → $304 | +17.69% | Oct 21, 2025 |
| Wells Fargo | Wells Fargo | Hold Initiates $280 | Hold | Initiates | $280 | +8.40% | Oct 13, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $330 | Strong Buy | Initiates | $330 | +27.75% | Sep 18, 2025 |
| Mizuho | Mizuho | Buy Maintains $270 → $290 | Buy | Maintains | $270 → $290 | +12.27% | Aug 1, 2025 |
| Stifel | Stifel | Hold Maintains $240 → $270 | Hold | Maintains | $240 → $270 | +4.53% | Aug 1, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $294 → $300 | Buy | Maintains | $294 → $300 | +16.14% | Aug 1, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.